50 Pioglitazone showed a strong trend toward the primary outcome but did not achieve statistical significance over placebo.
← all excerpts
Perspectives on Nonalcoholic Fatty Liver Disease: An Overview of Present and Future Therapies.
1
—
—
50 Pioglitazone showed a strong trend toward the primary outcome but did not achieve statistical significance over placebo.